Probing the existence of g protein-coupled receptor dimers by positive and negative ligand-dependent cooperative binding

被引:84
作者
Albizu, Laura
Balestre, Marie-Noelle
Breton, Christophe
Pin, Jean-Philippe
Manning, Maurice
Mouillac, Bernard
Barberis, Claude
Durroux, Thierry
机构
[1] CNRS, INSERM, UMR 5203, Inst Genom Fonct, F-34094 Montpellier 5, France
[2] INSERM, U661, Montpellier, France
[3] Univ Montpellier 1, Montpellier, France
[4] Univ Montpellier 2, Montpellier, France
[5] Univ Sci & Tech Lille Flandres Artois, Dept Physiol, Lab Neuroendocrinol Dev, Unuite Propre Rech & Enseignement Super,Equipe Ac, Villeneuve Dascq, France
[6] Med Coll Ohio, Dept Biochem & Canc Biol, Toledo, OH USA
关键词
D O I
10.1124/mol.106.025684
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
An increasing amount of ligand binding data on G protein-coupled receptors ( GPCRs) is not compatible with the prediction of the simple mass action law. This may be related to the propensity of most GPCRs, if not all, to oligomerize. Indeed, one of the consequences of receptor oligomerization could be a possible cross-talk between the protomers, which in turn could lead to negative or positive cooperative ligand binding. We prove here that this can be demonstrated experimentally. Saturation, dissociation, and competition binding experiments were performed on vasopressin and oxytocin receptors expressed in Chinese hamster ovary or COS-7 cells. Linear, concave, and convex Scatchard plots were then obtained, depending on the ligand used. Moreover, some competition curves exhibited an increase of the radiotracer binding for low concentrations of competitors, suggesting a cooperative binding process. These data demonstrate that various vasopressin analogs display either positive or negative cooperative binding. Because positive cooperative binding cannot be explained without considering receptor as multivalent, these binding data support the concept of GPCR dimerization process. The results, which are in good accordance with the predictions of previous mathematical models, suggest that binding experiments can be used to probe the existence of receptor dimers.
引用
收藏
页码:1783 / 1791
页数:9
相关论文
共 37 条
[1]   Dopamine D2 receptor dimer formation -: Evidence from ligand binding [J].
Armstrong, D ;
Strange, PG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (25) :22621-22629
[2]   CHARACTERIZATION OF A NOVEL, LINEAR RADIOIODINATED VASOPRESSIN ANTAGONIST - AN EXCELLENT RADIOLIGAND FOR VASOPRESSIN V-1A RECEPTORS [J].
BARBERIS, C ;
BALESTRE, MN ;
JARD, S ;
TRIBOLLET, E ;
ARSENIJEVIC, Y ;
DREIFUSS, JJ ;
BANKOWSKI, K ;
MANNING, M ;
CHAN, WY ;
SCHLOSSER, SS ;
HOLSBOER, F ;
ELANDS, J .
NEUROENDOCRINOLOGY, 1995, 62 (02) :135-146
[3]  
BARBERIS C, 1993, 4 INT VAS C 1993 MAY, P69
[4]   VASOPRESSIN ANALOGUES WITH SELECTIVE PRESSOR ACTIVITY [J].
BERDE, B ;
BOISSONNAS, RA ;
STURMER, E ;
HUGUENIN, RL .
EXPERIENTIA, 1964, 20 (01) :42-&
[5]   Direct identification of human oxytocin receptor-binding domains using a photoactivatable cyclic peptide antagonist -: Comparison with the human V1a vasopressin receptor [J].
Breton, C ;
Chellil, H ;
Kabbaj-Benmansour, M ;
Carnazzi, E ;
Seyer, R ;
Phalipou, S ;
Morin, D ;
Durroux, T ;
Zingg, H ;
Barberis, C ;
Mouillac, B .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (29) :26931-26941
[6]   Two aromatic residues regulate the response of the human oxytocin receptor to the partial agonist arginine vasopressin [J].
Chini, B ;
Mouillac, B ;
Balestre, MN ;
TrumppKallmeyer, S ;
Hoflack, J ;
Hibert, M ;
Andriolo, M ;
Pupier, S ;
Jard, S ;
Barberis, C .
FEBS LETTERS, 1996, 397 (2-3) :201-206
[7]   Kinetic studies of co-operativity at atrial muscarinic M(2) receptors with an ''infinite dilution'' procedure [J].
Christopoulos, A ;
Lanzafame, A ;
Ziegler, A ;
Mitchelson, F .
BIOCHEMICAL PHARMACOLOGY, 1997, 53 (06) :795-800
[8]   G protein-coupled receptor allosterism and complexing [J].
Christopoulos, A ;
Kenakin, T .
PHARMACOLOGICAL REVIEWS, 2002, 54 (02) :323-374
[9]   Conserved aromatic residues in the transmembrane region VI of the V1a vasopressin receptor differentiate agonist vs. antagonist ligand binding [J].
Cotte, N ;
Balestre, MN ;
Aumelas, A ;
Mahé, E ;
Phalipou, S ;
Morin, D ;
Hibert, M ;
Manning, M ;
Durroux, T ;
Barberis, C ;
Mouillac, B .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 2000, 267 (13) :4253-4263
[10]  
DEMEYTS P, 1976, J SUPRAMOL STR CELL, V4, P241